A trial of cordycepin in combination with the adenosine deaminase inhibitor pentostatin for acute lymphocytic leukaemia issued a preliminary account in 2000 [194], but unfortunately, this study has still not issued a final report. This evidence concerns the gene ADA and acute lymphoblastic leukemia.